Constantine S. Tam, and Sarah Kamel. 2016. “Comment on Lipsky Et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib”. Haematologica 101 (3). Pavia, Italy, e123-e123. https://doi.org/10.3324/haematol.2015.139030.